Inventor
THANOS CHRISTOPHER
US27 patents
⚠️ This page may combine multiple inventors who share the name “THANOS CHRISTOPHER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
9 patentsUS11992506B2May 28, 2024
Stem cell derived pancreatic islet differentiation
VERTEX PHARMA2 citations63
US12194138B2Jan 14, 2025
Devices and methods for delivering therapeutics
VERTEX PHARMA0 citations61
US12515028B2Jan 6, 2026
Multicompartment macroencapsulation devices
VERTEX PHARMA0 citations60
US12377252B2Aug 5, 2025
Implantation devices, system, and methods
VERTEX PHARMA0 citations57
US12544545B2Feb 10, 2026
Macroencapsulation devices
VERTEX PHARMA0 citations56
US11951206B2Apr 9, 2024
Cell housing device
VERTEX PHARMA0 citations54
US11471398B2Oct 18, 2022
Devices and methods for delivering therapeutics
VERTEX PHARMA1 citations53
US12331334B2Jun 17, 2025
Modified urokinase-type plasminogen activator polypeptides and methods of use
VERTEX PHARMA0 citations47
US11613744B2Mar 28, 2023
Modified urokinase-type plasminogen activator polypeptides and methods of use
VERTEX PHARMA0 citations47
MADISON EDWIN L
5 patentsUS8519103B2Aug 27, 2013
Factor VII polypeptides that are modified and uses thereof
MADISON EDWIN L16 citations92
US8778870B2Jul 15, 2014
Modified factor IX polypeptides and uses thereof
MADISON EDWIN L24 citations90
US9795655B2Oct 24, 2017
Modified MT-SP1 proteases that inhibit complement activation
MADISON EDWIN L7 citations83
US9328339B2May 3, 2016
Modified factor IX polypeptides and uses thereof
MADISON EDWIN L4 citations71
US9145552B2Sep 29, 2015
Modified factor X polypeptides and uses thereof
MADISON EDWIN L0 citations52
CATALYST BIOSCIENCES INC
5 patentsUS9476037B2Oct 25, 2016
Factor VII polypeptides that are modified and uses thereof
CATALYST BIOSCIENCES INC8 citations84
US11203749B2Dec 21, 2021
Factor VII polypeptides that are modified and uses thereof
CATALYST BIOSCIENCES INC1 citations73
US10160961B2Dec 25, 2018
Factor VII polypeptides that are modified and uses thereof
CATALYST BIOSCIENCES INC2 citations73
US10982203B2Apr 20, 2021
Modified factor IX polypeptides and uses thereof
CATALYST BIOSCIENCES INC0 citations60
US9856467B2Jan 2, 2018
Modified factor X polypeptides and uses thereof
CATALYST BIOSCIENCES INC0 citations52
SUTRO BIOPHARMA INC
4 patentsUS9988619B2Jun 5, 2018
Non-natural amino acid tRNA synthetases for pyridyl tetrazine
SUTRO BIOPHARMA INC40 citations91
US9938516B2Apr 10, 2018
Non-natural amino acid tRNA synthetases for para-methylazido-L-phenylalanine
SUTRO BIOPHARMA INC40 citations91
US10179909B2Jan 15, 2019
Non-natural amino acid tRNA synthetases for pyridyl tetrazine
SUTRO BIOPHARMA INC5 citations70
US10975150B2Apr 13, 2021
Anti-CD74 antibodies, compositions comprising anti-CD74 antibodies and methods of using anti-CD74 antibodies
SUTRO BIOPHARMA INC1 citations61